Last updated on November 2017


Brief description of study


Detailed Study Description

A phase III, randomized, open-label, comparative safety and efficacy trial of intravenous iron isomaltoside (Monofer) and iron sucrose in subjects with iron deficiency anaemia who are intolerant or unresponsive to oral iron therapy or in whom the haemoglobin measurement in Investigator's opinion were sufficiently low as to require rapid repletion of iron stores to minimize the risk of receiving a blood transfusion

Clinical Study Identifier: TX11026


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Betsy Moclair

Manhattan Medical Research
New York, NY USA
  Connect »

Elena Corona

Grossmont Center for Clinical Research
San Diego, CA USA
  Connect »

Cherish Semeski

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK USA
  Connect »


Elite Clinical Studies, LLC
Phoenix, AZ USA
  Connect »